To Determine The Efficacy and Safety of GDC-0449 in Patients With Basal Cell Nevus Syndrome (BCNS)
NCT00957229
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
41
Enrollment
OTHER
Sponsor class
Conditions
Basal Cell Nevus Syndrome
Gorlin Syndrome
Interventions
DRUG:
GDC-0449
Sponsor
UCSF Benioff Children's Hospital Oakland
Collaborators
[object Object]